mannose has been researched along with pulmicort in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chokshi, NV; Khatri, HN; Patel, BM; Patel, MM; Rawal, SU; Shah, NN; Sinhmar, GK | 1 |
| Abreu, S; Chaminade, P; Desmaële, D; Fattal, E; Moine, L; Pinheiro do Nascimento, L; Reynaud, F; Tsapis, N; Vergnaud, J | 1 |
2 other study(ies) available for mannose and pulmicort
| Article | Year |
|---|---|
Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
Topics: Body Weight; Budesonide; Cell Line; Cell Survival; Colon; Drug Carriers; Drug Liberation; Engineering; Humans; Inflammatory Bowel Diseases; Kinetics; Lipids; Mannose; Nanoparticles; Organ Size; Surface Properties | 2018 |
Mannosylation of budesonide palmitate nanoprodrugs for improved macrophage targeting.
Topics: Animals; Biological Availability; Budesonide; Cell Survival; Cells, Cultured; Cytokines; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Macrophages; Mannose; Mice; Nanoparticles; Prodrugs; Tissue Distribution | 2022 |